Tags » Systemic Lupus Erythematosus

How I Came To Know Pure Happiness

2016 was my year of personal development, growth, and understanding what self-love and self-compassion meant. Last year, I experienced some of my most trying and lowest points, but I also encountered some of the best life-changing experiences I’ve had thus far. 863 more words

Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by self-reactive lymphocytes that mount an immune response against the body’s own tissues. It is an example of a type III hypersensitivity, which is linked with defects in the immune system’s ability to develop self-tolerance. 381 more words

Physiology & Pathology

Nunya

I have been disturbed for the past week regarding something that a co-worker said to me and also upset at myself for even engaging in the conversation and telling her my business to “prove her wrong.” Or more so to prove to her that I was doing everything in my power to make myself better.   1,407 more words

Lupus

Heart Failure and Systemic Lupus Erythematosus

Kim et al report on the prevalence of heart failure in patients with systemic lupus erythematosus (SLE).

Abstract

Background

Although case series suggest a higher burden of cardiovascular risk factors in patients with systemic lupus erythematosus (SLE) compared with the… 212 more words

CEP 33779

CEP-33779, CEP33779
CAS 1257704-57-6
Chemical Formula: C24H26N6O2S
Molecular Weight: 462.57
Elemental Analysis: C, 62.32; H, 5.67; N, 18.17; O, 6.92; S, 6.93

N-(3-(4-methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-triazolopyridin-2-amine

PRECLINICAL Treatment of Rheumatoid Arthritis, Agents for Colorectal Cancer Therapy Systemic Lupus Erythematosus, 2,807 more words

Preclinical Drugs

ACR/ARHP 2016: Study Addresses Possible Impact of H.P. Acthar® Gel on Use of Corticosteroids Among Patients with Rheumatoid Arthritis, Lupus, and Dermatomyositis/Polymyositis

CHESTERFIELD, United Kingdom,  Mallinckrodt plc  presented on Nov. 17, 2016, results of a retrospective, claims-based analysis that indicated the use of H.P. Acthar® Gel (repository corticotropin injection) may be associated with reductions in corticosteroid (CS) requirements among patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and dermatomyositis and polymyositis (DM/PM). 976 more words

Scientific Sessions

Spinning right out of control

As weekends go, the last one wasn’t really the best.  Actually, it was probably one of the worst, in the grand scale of things.  Recent bugs… 593 more words

What Is Lupus